HCV in Dialysis, Decompensated and Other Special Patient Populations

HCV in Dialysis, Decompensated and Other Special Patient Populations

AUDIO ONLY

Robert Fontana, M.D., provides an overview of the efficacy and safety of novel antiviral agents in special patient populations.

This presentation is part of the UMI – 12th Annual Advanced Liver Disease and Liver Transplantation Update 2017.  Learn more about the additional presentations in this audio series.

 

 


Created by

Colleague Connection

Related Presenters

Robert Fontana, MD

Robert Fontana, MD

Professor & Medical Director, Liver Transplantation

Dr. Fontana is a Professor of Medicine and the Medical Director of Liver Transplantation. He also directs the Transplant Hepatology Fellowship Program. He is recognized as a national expert in translational studies involving the treatment ...

View full profile